Leipzig University, in Leipzig in the Free State of Saxony, Germany, is one of the world's oldest universities and the second-oldest university in Germany.

During the past decade, University of Leipzig conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 19 clinical trials were completed, i.e. on average, 46.3% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 10 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Leipzig" #1 sponsor was "Fred Hutchinson Cancer Center" with 12 trials, followed by "University of Leipzig" with 12 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "Celgene" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Leipzig" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "University of Leipzig" with 4 trials as a collaborator, "European Society of Anaesthesiology" with 3 trials as a collaborator and "German Research Foundation" with 2 trials as a collaborator. Other collaborators include 67 different institutions and companies that were collaborators in the rest 75 trials.

According to Clinical.Site data, the most researched conditions in "University of Leipzig" are "Refractory Chronic Lymphocytic Leukemia" (9 trials), "Recurrent Adult Acute Lymphoblastic Leukemia" (7 trials), "Recurrent Adult Acute Myeloid Leukemia" (6 trials), "Recurrent Adult Hodgkin Lymphoma" (6 trials) and "Recurrent Small Lymphocytic Lymphoma" (6 trials). Many other conditions were trialed in "University of Leipzig" in a lesser frequency.

Most popular intervention types in "University of Leipzig" are "Drug" (41 trials), "Procedure" (28 trials), "Other" (17 trials), "Device" (15 trials) and "Radiation" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Fludarabine Phosphate" (6 trials), "Mycophenolate Mofetil" (6 trials), "Peripheral Blood Stem Cell Transplantation" (6 trials) and "Total-Body Irradiation" (6 trials). Other intervention names were less common.

The vast majority of trials in "University of Leipzig" are 89 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Leipzig". undefined are not yet recruiting, 12 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 56 completed trials in University of Leipzig, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in University of Leipzig, 10 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 30 trials that are defined as “Not Applicable".